IKKε Is Part of a Novel PMA-Inducible IκB Kinase Complex
By R. Peters, S. Liao, T. Maniatis. 2000
310 citations recorded by the source corpus.
Subfields: Cancer Research, Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/c477ff16efd502f8056ff016f57b65f493f2c341
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Immunology
In Oncology
Citations in the corpus
- NF-κB: pivotal mediator or innocent bystander in atherogenesis? (2001, background): “Recently a new inducible kinase complex was identified that is distinct from the well characterized IKK complex (36).”
- Integrative genomic approaches identify IKBKE as a breast cancer oncogene. (2007, background): “The following antibodies were used: anti-IKK3 K-14 (Santa Cruz, CA) (Figure 3) or anti-IKK3 c-terminal (Sigma) (Figures 3–6), anti-IkBa C-15 (Santa Cruz, CA), anti-NF-kB H-119 (Santa Cruz, CA), anti-MEK1/2 (Cell Signaling), anti-Cyclin D1 (Neomarkers), or anti-IRF3 (Santa Cruz, CA).”
- Identification of NAP1, a Regulatory Subunit of IκB Kinase-Related Kinases That Potentiates NF-κB Signaling (2003, background): “T2K) and IKKe (also known as IKKi), were identified and shown to be present in complexes distinct from the classical IKK complex (4, 32 , 33, 40, 43).”